T h e commonly used trypsin substrate Na-benzoyl-m.-arginine p-naphthylamide ( B A N A ) was not cleaved by either GB or SCTPA. BANA caused 50% inhibition of G B at 2 x 1 0 F J M when assayed with MUGB, and 50% inhibition of SCTPA at lo-' M when assayed with substrate S-2288.
We conclude that the proteinases SCTPA and GB (although not necessarily identical) are more closely related t o each other in their location, size, substrate specificity and inhibition characteristics than to the other trypsin-like proteinases. in spite of using high dosages, the desirable therapeutic results are not achieved. Moreover, there appears to be no concensus on the best dosage for a particular type of lcukaemia [4] . The unresponsiveness to MTX in such cases has been attributed to the development of resistance in cancer cells against this drug. T h e mechanisms involved in the development of such resistance include: (a) increased production of dihydrofolate reductase (DHFK; the target enzyme in MTX therapy) by gene amplification, ( b ) decreased polyglutamation of MTX inside the cell, (c) decreased membrane transport of MTX, and ( d ) decreased affinity of DHFK for MTX [ I ] . A few years ago it was reported that blast cells of acute myelogcnous leukacmia Table 1 . /'tf/MLY binding by h i i t t i a n leiikrierriiir (.ell l w r t (~. s Human leukaemia cells were obtaified from patients before putting them o n chemotherapy. These leukaemia cells were isolated from the heparinized blood and the lysatcs were prepared from them as previously described I i 01. [ The ineffectiveness of MTX in the treatment of acute myelogenous Ieukaemia and chronic myelogenous leukaemia is quite well known. The presence of a form of DHFR having low affinity for MTX in these previously untreated leukaemia cells could explain why this drug does not appear to be highly effective in the management of this disease. Clinically, it suggests that ordinary doses o f MTX may not be highly effective as part of initial therapy in most cases of acute H # . It has been shown in our laboratory that a high-affinity binder of MTX present in L1210 leukaemia cells binds the same amount of the drug at pH 4.8 and pH 7.2, whereas a low-affinity binder of this drug would bind very little MTX at pH 4.8 but quite avidly at pH 7.2. Therefore, the direct binding of ['HIMTX by cell lysates could be used to quantify high-and low-affinity binders of this drug if these were present in certain cells. [3, 41 . Apoptosis, the physiological mode of cell death, is representative of an endogenous suicide mechanism which can be selectively triggered by the cell in response to as yet largely unknown stimuli. During apoptosis, a series of well-ordered degenerative changes occur within the dying cell which ultimately result in the degradation of the nuclear DNA into oligonucleosome chains and the fragmentation of the cell into neat 'bite-size' pieces for efficient disposal by neighbouring cells or marauding macrophages. There is little evidence to support the widely held view that transcription and translation of specific genes is required for apoptosis to
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